Mind+ Neurology is advancing medical research and offering hope to patients living with migraine. Mind+ is an authorized site for a new Episodic Migraine clinical trial.

Eptinezumab vs placebo significantly reduces acute headache medication in patients with migraine and those with medication overuse.

Chronic migraines are more than just bad headaches—they’re a serious condition that can affect your daily life. People who ...

"ShiraTronics commences chronic migraine therapy trial" was originally created and published by Medical Device Network, a ...

The novel migraine-abortive agents lasmiditan, rimegepant, and ubrogepant effectively treated migraine pain in triptan-insufficient responders.

Teva Pharmaceutical Industries has presented positive data from its Phase 3 SPACE study, demonstrating the efficacy and ...

This update of a systematic review evaluated the effectiveness of spinal manipulations as a treatment for migraine headaches. Amed, Embase, MEDLINE, CINAHL, Mantis, Index to Chiropractic Literature, ...